Solvgen Case

In: Business and Management

Submitted By Moogooch222
Words 612
Pages 3
Case 10-1 SolvGen Inc. In this case study, we deal with two separate agreements between SolvGen and Careway Pharma that are being audited for the possible sale of SolvGen to Direct Drugs, Inc. First, is the research and development agreement between SolvGen and Careway. And second, is the license and distribution agreement between the aforementioned. These agreements are both written and contractually binding and are within the scope of Multiple Deliverable Arrangements. The deliverables for the arrangements described in the case study are: a five-year research and development agreement and a five-year license and distribution agreement. For the five-year research and development agreement, SolvGen would use its best efforts to further develop proprietary instrument systems that have been under development for nearly 18 months and are expected to be ready for commercial launch in the near future. Under the license and distribution agreement, SolvGen will be paid for proprietary instrument system as it is purchased by Careway.

The exclusive negotiation payment - $ 1million (paid in December 1, 2005) cannot be recognized in 2005 because it is not yet earned. The contract will start in 2006 that’s when the amount will start being spread over the 5 year life contract. SolvGen can only recognize $ 200,000 in 2006. The contract signing payment - $ 2 million (paid January 1, 2006) can be recognized over 5 year life of contract because even though they are nonrefundable milestone payments, it does not mean that SolvGen will earn all this money in 2006. The commercial launch of instrument system Version 1 - $ 5 million (paid in March 31, 2006 upon its commercialization) can be recognized once SolvGen delivers the instrument system (or provide the service) because if it has not delivered or provided the service, this amount would be unearned revenue. For the last two…...

Similar Documents

Solvgen

...Case 10-1 SolvGen Inc. Direct Drugs Inc. (Direct) is planning to acquire SolvGen Inc. (SolvGen or the Company), a publicly owned company, during the fourth quarter of fiscal year ending December 31, 2006. Direct has engaged our audit engagement team to perform due diligence procedures, with an emphasis on the review of two separate material agreements: (1) a research and development agreement and (2) a license and distribution agreement, both executed by SolvGen during the first quarter of fiscal year 2006. Direct’s management provided the engagement team with the following memo describing the Company’s revenue recognition policy: MEMO To: Audit Engagement Team From: CFO, SolvGen Inc. Subject: Revenue Recognition for Research and Development and License and Distribution Agreements Date: November 30, 2006 SolvGen Inc. (the Company), an SEC registrant, is a pharmaceutical development company. SolvGen entered into a five-year research and development agreement with Careway Pharma Inc. (Careway) on January 1, 2006. The research and development agreement calls for SolvGen to use its best efforts to further develop proprietary instrument systems that have been under development for nearly 18 months and are expected to be ready for commercial launch in the near future. In connection with executing the research and development arrangement, SolvGen and Careway also entered into a five-year license and......

Words: 500 - Pages: 2

Solvgen Case 10-1

...Case 10-1 SolvGen Inc. In this case study, we deal with two separate agreements between SolvGen and Careway Pharma that are being audited for the possible sale of SolvGen to Direct Drugs, Inc. First, is the research and development agreement between SolvGen and Careway. And second, is the license and distribution agreement between the aforementioned. These agreements are both written and contractually binding and are within the scope of Multiple Deliverable Arrangements. The deliverables for the arrangements described in the case study are: a five-year research and development agreement and a five-year license and distribution agreement. For the five-year research and development agreement, SolvGen would use its best efforts to further develop proprietary instrument systems that have been under development for nearly 18 months and are expected to be ready for commercial launch in the near future. Under the license and distribution agreement, SolvGen will be paid for proprietary instrument system as it is purchased by Careway. The exclusive negotiation payment - $ 1million (paid in December 1, 2005) cannot be recognized in 2005 because it is not yet earned. The contract will start in 2006 that’s when the amount will start being spread over the 5 year life contract. SolvGen can only recognize $ 200,000 in 2006. The contract signing payment - $ 2 million (paid January 1, 2006) can be recognized over 5 year life of contract because even though they are nonrefundable......

Words: 317 - Pages: 2

Solvgen Case

...Solvgen Case Case 10-1 SolvGen Inc. In this case study, we deal with two separate agreements between SolvGen and Careway Pharma that are being audited for the possible sale of SolvGen to Direct Drugs, Inc. First, is the research and development agreement between SolvGen and Careway. And second, is the license and distribution agreement between the aforementioned. These agreements are both written and contractually binding and are within the scope of Multiple Deliverable Arrangements. The deliverables for the arrangements described in the case study are: a five-year research and development agreement and a five-year license and distribution agreement. For the five-year research and development agreement, SolvGen would use its best efforts to further develop proprietary instrument systems that have been under development for nearly 18 months and are expected to be ready for commercial launch in the near future. Under the license and distribution agreement, SolvGen will be paid for proprietary instrument system as it is purchased by Careway. The exclusive negotiation payment - $ 1million (paid in December 1, 2005) cannot be recognized in 2005 because it is not yet earned. The contract will start in 2006 that’s when the amount will start being spread over the 5 year life contract. SolvGen can only recognize $ 200,000 in 2006. The contract signing payment - $ 2 million (paid January 1, 2006) can be recognized over 5 year life of contract because even though they are......

Words: 1335 - Pages: 6

Case

...case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case case......

Words: 3640 - Pages: 15

Case

...Join now! Login Support Other Term Papers and Free Essays Browse Papers Business / Timbuk2 Case Study Timbuk2 Case Study Term Papers Timbuk2 Case Study and over other 20 000+ free term papers, essays and research papers examples are available on the website! Autor: santhanam.vikram 09 December 2013 Tags: Words: 723 | Pages: 3 Views: 86 Read Full Essay Join Now! CASE STUDY: TIMBUK2 1.) Consider the two categories of products that Timbuk2 makes and sells. For the custom messenger bag, what are the key competitive dimensions that are driving sales? Are their competitive priorities different for the new laptop bags sourced in China? Some of the competitive advantage which are the key factors of Timbuk2 bags are:-  Quality  Durable  Reliable  Not prone to defects  Custom made bags for each of the customers  The quick delivery of bags  The rave review which the company gets for its bags i.e. it basically carries a good name in the market  For its laptop bags, even though they are manufactured in china, the designing is done in San Francisco. so the exclusivity remains  Cost effective manufacture of laptop bags in china  Being able to adopt to changes in demand and fashion By manufacturing the bags in china the company saved the manufacturing cost but lost their niche of manufacturing and selling in America itself. The general perception of it being a Chinese product led to customers felling......

Words: 564 - Pages: 3

Case

.../InstructorResourceManual.pdf‎ The case was prepared by Mark S. Beasley, Ph.D. and Frank A. Buckless, Ph.D. of North Carolina State University and .... Case 1.1: Ocean Manufacturing, Inc. Ocean Manufacutring Inc The New Client Acceptance ... www.studymode.com/.../ocean-manufacutring-inc-the-new-client-accept...‎ Ocean Manufacturing, Inc.: the New Client Acceptance Decision: Case 1.1 Ocean ... Problem Solution: Harrison-Keyes Inc. Ayodeji Ajayi University of Phoenix ... Ocean Manufacturing, Inc.: The New Client Acceptance ... www.freecasestudysolutions.com/case-study-Ocean-Manufacturing-Inc-...‎ Case 1.1 Ocean Manufacturing, Inc.: The New Client Acceptance Decision Ocean Manufacturing, Inc. is recommended as a ... ORDER NEW SOLUTIONS ... Solution Manual for Auditing Cases An Interactive Learning ... testbanksfor.com › All test banks and solution manuals‎ Download Solution Manual for Auditing Cases An Interactive Learning Approach 5th Edition by Beasely. Solution Of Ocean Manufacturing Inc Free Essays 1 - 30 www.papercamp.com/group/solution-of-ocean-manufacturing.../page-0‎ Free Essays on Solution Of Ocean Manufacturing Inc for students. ... ACCT 805AE Case 4 Ocean Manufacturing, Inc The Osprey Group Feb 21, ... Auditing: r c aSe S t h at diSc uSS topicS rel ated to thiS Section 1.1 Ocean Manufacturing, Inc. . Case 1 1 Ocean Manufacturing Inc Free Essays 1 - 30 www.papercamp.com/group/case-1-1-ocean-manufacturing-inc/page-0‎ Case 1.1 Ocean Manufacturing, Inc.:......

Words: 447 - Pages: 2

Case

...1. According to the case, I think the big problem is the revenue recognition date. 2. Alternative 1, exclusive negotiation payment ($1 million) should be recognized on December 1, 2009 because it paid on that day. Contract signing payment ($2 million) should be recognized on January 1, 2010 because SolvGen and Careway also entered into a five-year license and distribution agreement dated January 1, 2010. Instrument system Version 1 ($5 million) should be recognized when of instrument system Version 1 is ready for commercial launch. Instrument system Version 2 &3 ($5 million) also should be recognized when of instrument system Version 2 &3 is ready for commercial launch. Alternative 2, exclusive negotiation payment ($1 million) should be recognized over the five-year research and development agreement term, beginning with the date the R&D services begin. Contract signing payment ($2 million) should be recognized over the five-year research and development agreement term, beginning with the date the R&D services begin. Instrument system Version 1 ($5 million) should be recognized over the performance period. Instrument system Version 2 &3 ($5 million) should be recognized in their entirety upon achievement of each milestone. 3. Research 1, ASC 605-28 notes that it "specifies the accounting for research or development deliverables or units of accounting that include milestones that are accounted for under the milestone method of revenue......

Words: 703 - Pages: 3

Case to Case

...CASE STUDY 2 I. THE ARALIN TEACHER Mrs. Boots De Vola was assigned to teach the first section in third year level. She assumed that she is an effective and efficient teacher in Araling Panlipunan because of that. There are many teachers qualified and much deserving to teach the star section. Now, the students are complaining of the expenses regarding projects, special projects and the way she behave in classroom. II. HISTORY AND BACKGROUND OF THE FACTS Mrs. Boots De Vola have underwent the process of being LSB teacher, PSB teacher, before she was declared as regular teacher in Banana National High School. It has been five years that she handled Aralin in section one. There are congruency on each year complaint but since the students are afraid of failing her subject they remained quiet. I seldom hear news about her projects and the money she collected from her advisory class. Every single mistake has an specified amount to be collected as fine, but the students don’t know where these money will be spent. Another concern about Mrs. Boots De Vola is the way she handled and treated her students. She always nag and shout to students, for her it’s the way of disciplining her students. Some of the students chose to dropped schooling because they felt being degraded and they do not have money for everyday fine. Lately, a mother asked her about the special project of her son amounting one hundred thirty pesos. The project was properly discussed, but we found out that......

Words: 699 - Pages: 3

Case

...A Guide to Case Analysis I keep six honest serving men (They taught me all I knew); Their names are What and Why and When; And How and Where and Who. — Rudyard Kipling 2 A Guide to Case Analysis In most courses in strategic management, students use cases about actual companies to practice strategic analysis and to gain some experience in the tasks of crafting and implementing strategy. A case sets forth, in a factual manner, the events and organizational circumstances surrounding a particular managerial situation. It puts readers at the scene of the action and familiarizes them with all the relevant circumstances. A case on strategic management can concern a whole industry, a single organization, or some part of an organization; the organization involved can be either profit seeking or not-for-profit. The essence of the student’s role in case analysis is to diagnose and size up the situation described in the case and then to recommend appropriate action steps. Why Use Cases to Practice Strategic Management? A student of business with tact Absorbed many answers he lacked. But acquiring a job, He said with a sob, “How does one fit answer to fact?” The foregoing limerick was used some years ago by Professor Charles Gragg to characterize the plight of business students who had no exposure to cases.1 The facts are that the mere act of listening to lectures and sound advice about managing does little for anyone’s management skills and that the accumulated managerial......

Words: 7354 - Pages: 30

Acc Case 10-1

...GROUP CASE 10-1 1. From the documents of "Deliverables" on blackboards, although the words “deliverable” did not have a clear definition, there are lots of potential deliverables that entities may considering. We can find that in the case 10-1 SolvGen Inc., the selling of proprietary instrument systems, which is under the five-year license and distribution agreement, is a deliverable. From the case we know that Careway will have the right to market and distribute the proprietary instrument systems and pay SolvGen for each proprietary instrument system in the future. The five-year license and distribution agreement requires Careway to pay SolvGen for each proprietary instrument system when it is purchased by Careway. A deliverable must have objective value on a stand-alone basis. The five-year research and development agreement doesn't have a deliverable because it's integrated with the five-year license and distribution agreement and doesn't have a stand-alone value. According to FASB ASC 605-25, it's not a deliverable.  2. According to FASB Statement of Financial Accounting Concepts(CON) 5,Recognition and Meaurement in Financial Statements of Business Enterprises, revenue is considered “earned” if an entity has substantially accomplished what it must do to be entitled to the contractual benefits. Revenue is “realizable” when related assets received are readily convertible to cash or claims to cash. In this case, SolvGen should recognize the nonrefundable......

Words: 1076 - Pages: 5

Solvgen Inc

...SolvGen Inc. entered into a five-year research and development agreement with Careway Pharma Inc. In connection with executing the research and development arrangement, SolvGen and Careway also entered into a five-year license and distribution agreement. Under the terms of the research and development agreement, SolvGen retains all intellectual rights to the results and is entitled to the following five nonrefundable milestone payments from Careway: 1. Exclusive negotiation payment — $1 million (paid December 1, 2005). 2. Contract signing payment — $2 million (paid January 1, 2006). 3. Commercial launch of instrument system Version 1 — $5 million (paid March 31, 2006, upon commercial launch of the instrument system). 4. Commercial launch of instrument system Version 2 — $5 million (not yet paid). 5. Commercial launch of instrument system Version 3 — $5 million (not yet paid). Under the license and distribution agreement, Careway will have the right to market and distribute the proprietary instrument systems. Careway is required to pay SolvGen for each proprietary instrument system as it is purchased by Careway. SolvGen recognizes the nonrefundable milestone payments when the payments are received over the remaining estimated contractual life of the agreements. Based on an evaluation of the circumstances, there are two deliverables in this arrangement that should be considered for separation: a. A license and distribution deliverable b. A research...

Words: 493 - Pages: 2

Solvgen Case

...Group 9, Cohort B | SolvGen Case | Revenue Recognition | Martin French, Neeharika Komatineni, Cory Strengholt, Zhi Qin 3/6/2012 | In our paper, we will present several alternatives to the questions for the SolvGen case, and we will select one of those alternatives as what we have faith in to be the most correct answer. Deliverables: Option 1: There is one deliverable in this case, and that is Careway’s future marketing and distribution of the proprietary instrument systems to potential customers. We assume that the research and development is of no value to Careway, as they are not entitled to any of the intellectual rights to the results of the research and development agreement (even in the event of default by the SolvGen). We believe that the arrangement is merely an agreement to market and distribute the instrument systems. The milestone payments are just the upfront costs as Careway isn’t truly getting any benefits at the time that they make those payments. Option 2: There are two deliverables in this case; one being the research and development agreement between SolvGen and Careway, and the other being the licensing and distribution agreement. People choosing this option believe that the research and development work completed by SolvGen, has inherent value to Careway, and is therefore a deliverable. Solution: Our panel decided that Option 1 was the more accurate alternative. On a stand-alone basis, the research and development agreement has......

Words: 745 - Pages: 3

Case 10-1

...Case 10-1 SolvGen Inc. Direct Drugs Inc. (Direct) is planning to acquire SolvGen Inc. (SolvGen or the Company), a publicly owned company, during the fourth quarter of fiscal year ending December 31, 2010. Direct has engaged our audit engagement team to perform due diligence procedures, with an emphasis on the review of two separate material agreements: (1) a research and development agreement and (2) a license and distribution agreement, both executed by SolvGen during the first quarter of fiscal year 2010. Direct’s management provided the engagement team with the following memo describing the Company’s revenue recognition policy: MEMO To: Audit Engagement Team From: CFO, SolvGen Inc. Subject: Revenue Recognition for Research and Development and License and Distribution Agreements Date: November 30, 2010 SolvGen Inc. (the Company), an SEC registrant, is a pharmaceutical development company. SolvGen entered into a five-year research and development agreement with Careway Pharma Inc. (Careway) on January 1, 2010. The research and development agreement calls for SolvGen to use its best efforts to further develop proprietary instrument systems that have been under development for nearly 18 months and are expected to be ready for commercial launch in the near future. In connection with executing the research and development arrangement, SolvGen and Careway also entered into a five-year license and distribution agreement dated January 1, 2010. Under the terms of the research......

Words: 492 - Pages: 2

Case Case

...Case Analysis - FPL Energy FPL Energy is one of the nation’s leading independent generators of electricity. Dedicated to generating clean energy, 80 % of its capacity is fueled by clean and renewable resources. The United States is the nation with the largest generator of wind energy, and it operates the two largest solar fields in the world. FPL Group, with annual revenues of more than $8 billion, is one of the nation's largest providers of electricity-related services. Its principal subsidiary, Florida Power & Light Company, serves approximately 3.9 million customer accounts in Florida. FPL Energy, LLC, and FPL Group energy-generating subsidiary, is a leader in producing electricity from clean and renewable fuels. 2. Historical Overview FPL Group is a far different company today than the one Jim Broadhead joined in January of 1989 when he became president and chief executive officer. FPL Group was then engaged in a number of businesses unrelated to its core electric skills, including insurance and financial services, real estate, cable television, and agriculture. The company's principal subsidiary, Florida Power and Light, was considered a well-managed utility with an emphasis on quality. However, the utility's spiraling costs had resulted in electric rates among the highest in the Southeast. Today, FPL Group is nationally known as a high quality, efficient, and customer-driven organization focused on energy-related products and services. With a......

Words: 3471 - Pages: 14

Solvgen Case

...Research and Development and License and Distribution Agreements SolvGen Inc. (SolvGen), a Pharmaceutical development company has entered a research and development contract with Careway Pharma Inc. (Careway) lasting 5 years. According to the agreement, SolvGen is to commercially sell Careway’s recently built instrument systems to customers. They have received milestone payments from Careway during the past year. However, according to the Securities and Exchange Commission (SEC), these payments need to be accurately accounted for in conformity with the SEC’s regulations and rules. With regards to the deliverables for the arrangements, there are a few different deliverables described. The first is the research and development agreement between SolvGen and Careway. The second is the license and distribution agreement between SolvGen and Careway. These agreements are both written contractually binding arrangements that are within the field of multiple element arrangements. This is a multiple element arrangement due to the fact that it is a research and development program and is stretched over a long period of time. However, this does not apply to the nonrefundable milestone payments from Careway, because they are payments relating to research and development deliverables that are accounted for under the milestone method of revenue recognition. (SAB 101) The milestone payments received to date by SolvGen should be recognized as revenue over the expected period of......

Words: 486 - Pages: 2